111 related articles for article (PubMed ID: 185297)
1. Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event?
Boyle MD; Ohanian SH; Borsos T
J Immunol; 1976 Oct; 117(4):1346-50. PubMed ID: 185297
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
[TBL] [Abstract][Full Text] [Related]
3. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
Gee AP; Boyle MD; Borsos T
J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
[TBL] [Abstract][Full Text] [Related]
4. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
Boyle MD; Langone JJ; Ohanian SH; Borsos T
J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
[TBL] [Abstract][Full Text] [Related]
5. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
Ohanian SH; Borsos T
J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
Ohanian SH; Borsos T
J Immunol; 1975 Jan; 114(1 Pt 2):326-30. PubMed ID: 1167878
[TBL] [Abstract][Full Text] [Related]
8. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
Boyle MD; Ohanian SH; Borsos T
J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
[TBL] [Abstract][Full Text] [Related]
9. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T.
Boyle MD; Ohanian SH; Borsos T
J Immunol; 1976 May; 116(5):1272-5. PubMed ID: 178793
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
12. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
13. [Bleomycin-induced tumor cell lysis caused by antibodies and complement].
Bier J; Ohanian SH
Dtsch Zahnarztl Z; 1980 Jan; 35(1):102-4. PubMed ID: 6157512
[TBL] [Abstract][Full Text] [Related]
14. The modifications of the final stages of the complement reaction by alkali metal cations.
Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
Hammer CH; Shin ML; Abramovitz AS; Mayer MM
J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of membrane damage by C: exposure of hydrophobic sites on activated C proteins.
Shin ML; Paznekas WA; Abramovitz AS; Mayer MM
J Immunol; 1977 Oct; 119(4):1358-64. PubMed ID: 561127
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
Deng J; Gold D; LoVerde PT; Fishelson Z
Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
[TBL] [Abstract][Full Text] [Related]
19. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
20. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
